Curis Inc SEC filings CRIS
Curis Inc has 1,006 filings in SEC EDGAR's recent list, going back to Jun 3, 2005. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 19, 2026 (material agreement, unregistered share sale). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Nov 2, 2026 | Nov 18, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 23, 2026 | Nov 18, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 19, 2026 | Oct 16, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 424B4 | Prospectus | Aug 13, 2026 | — |
| EFFECT | Filing | Aug 12, 2026 | — |
| S-1 | Registration statement | Aug 10, 2026 | — |
| 8-K |
Current report
Listing notice
|
Jul 30, 2026 | Jul 24, 2026 |
| DRS | Filing | Jul 17, 2026 | — |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 4 | Insider transaction | Jul 9, 2026 | Jul 7, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jul 2, 2026 | Jul 2, 2026 |
| 8-K/A |
Amended current report
Bylaw or fiscal year change
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jul 1, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 25, 2026 |
| DEF 14A | Proxy statement | Jun 5, 2026 | Jun 25, 2026 |
| PRE 14A | Preliminary proxy statement | May 22, 2026 | Jun 25, 2026 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
May 22, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 14, 2026 | — |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Listing notice
|
May 1, 2026 | Apr 27, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 24, 2026 | — |
| ARS | Annual report to shareholders | Apr 21, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Apr 21, 2026 | May 19, 2026 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2026 | May 19, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 7, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 7, 2026 | — |
| 4 | Insider transaction | Apr 1, 2026 | Mar 31, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 27, 2026 | — |
| 10-K | Annual report | Mar 24, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| 4 | Insider transaction | Mar 23, 2026 | Mar 20, 2026 |
| EFFECT | Filing | Mar 20, 2026 | — |
| 8-K |
Current report
Results of operations
|
Mar 19, 2026 | Mar 19, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 4 | Insider transaction | Mar 18, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Mar 17, 2026 | Mar 17, 2026 |
| CORRESP | Letter to the SEC | Mar 17, 2026 | — |
| DEF 14A | Proxy statement | Feb 19, 2026 | Mar 17, 2026 |
| UPLOAD | Letter from the SEC | Feb 19, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 17, 2026 | — |
| S-3 | Shelf registration | Feb 13, 2026 | — |
| PRE 14A | Preliminary proxy statement | Feb 9, 2026 | Mar 17, 2026 |
| 8-K |
Current report
Listing notice
|
Feb 9, 2026 | Feb 3, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jan 23, 2026 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Bylaw or fiscal year change, Other events
|
Jan 8, 2026 | Jan 7, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| 8-K/A | Amended current report | Nov 13, 2025 | Nov 6, 2025 |
| S-8 | Employee stock plan registration | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Agreement ended, Acquisition or sale of assets, Results of operations, Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Listing notice
|
Oct 24, 2025 | Oct 20, 2025 |
| 8-K |
Current report
Listing notice
|
Aug 22, 2025 | Aug 21, 2025 |
| EFFECT | Filing | Aug 18, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| CORRESP | Letter to the SEC | Aug 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| S-1 | Registration statement | Aug 11, 2025 | — |
| 8-K |
Current report
Other events
|
Aug 8, 2025 | Aug 8, 2025 |
| 424B5 | Prospectus supplement | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 5, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 424B5 | Prospectus supplement | Jul 2, 2025 | — |
| FWP | Free writing prospectus | Jul 2, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jul 2, 2025 | Jul 1, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 4 | Insider transaction | May 22, 2025 | May 20, 2025 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
May 22, 2025 | May 20, 2025 |
| EFFECT | Filing | May 19, 2025 | — |
| CORRESP | Letter to the SEC | May 15, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 15, 2025 | — |
| UPLOAD | Letter from the SEC | May 13, 2025 | — |
| S-3 | Shelf registration | May 7, 2025 | — |
| 10-Q | Quarterly report | May 6, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 4 | Insider transaction | May 5, 2025 | May 1, 2025 |
| 3 | Initial insider ownership | May 5, 2025 | May 1, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 16, 2025 | — |
| ARS | Annual report to shareholders | Apr 10, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 10, 2025 | — |
| DEF 14A | Proxy statement | Apr 10, 2025 | May 20, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Mar 31, 2025 | — |
| PRE 14A | Preliminary proxy statement | Mar 31, 2025 | May 20, 2025 |
| 10-K | Annual report | Mar 31, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2025 | Mar 31, 2025 |
| 424B5 | Prospectus supplement | Mar 31, 2025 | — |
| FWP | Free writing prospectus | Mar 31, 2025 | — |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Other events
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Listing notice
|
Feb 27, 2025 | Feb 21, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| 4 | Insider transaction | Jan 30, 2025 | Jan 28, 2025 |
| EFFECT | Filing | Jan 7, 2025 | — |
| CORRESP | Letter to the SEC | Jan 3, 2025 | — |
| UPLOAD | Letter from the SEC | Dec 31, 2024 | — |
| S-3 | Shelf registration | Dec 23, 2024 | — |
| 10-Q | Quarterly report | Nov 14, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 1, 2024 | — |
| 424B5 | Prospectus supplement | Oct 30, 2024 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Oct 30, 2024 | Oct 28, 2024 |
| FWP | Free writing prospectus | Oct 29, 2024 | — |
| 10-Q | Quarterly report | Aug 1, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 1, 2024 | Aug 1, 2024 |
| S-8 | Employee stock plan registration | Jun 14, 2024 | — |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 4 | Insider transaction | May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Change to shareholder rights, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
May 23, 2024 | May 21, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 14, 2024 | May 14, 2024 |
| 10-Q | Quarterly report | May 7, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 7, 2024 | May 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Apr 15, 2024 | — |
| EFFECT | Filing | Apr 12, 2024 | — |
| CORRESP | Letter to the SEC | Apr 10, 2024 | — |
| ARS | Annual report to shareholders | Apr 10, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 10, 2024 | — |
| DEF 14A | Proxy statement | Apr 10, 2024 | May 21, 2024 |
| PRE 14A | Preliminary proxy statement | Mar 29, 2024 | Apr 10, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2024 | — |
| UPLOAD | Letter from the SEC | Feb 13, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Feb 12, 2024 | — |
| S-8 | Employee stock plan registration | Feb 8, 2024 | — |
| S-3 | Shelf registration | Feb 8, 2024 | — |
| 10-K | Annual report | Feb 8, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 8, 2024 | Feb 8, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 11, 2024 | Jan 11, 2024 |
| UPLOAD | Letter from the SEC | Jan 3, 2024 | — |
| CORRESP | Letter to the SEC | Dec 21, 2023 | — |
| 10-K/A | Amended annual report | Dec 21, 2023 | Dec 31, 2022 |
| UPLOAD | Letter from the SEC | Dec 12, 2023 | — |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change, Shareholder vote results
|
Sep 28, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Sep 28, 2023 | Sep 26, 2023 |
| DEF 14A | Proxy statement | Aug 18, 2023 | Sep 26, 2023 |
| PRE 14A | Preliminary proxy statement | Aug 4, 2023 | Sep 26, 2023 |
| 10-Q | Quarterly report | Aug 3, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 424B5 | Prospectus supplement | Jul 6, 2023 | — |
| 8-K |
Current report
Material agreement, Other events
|
Jul 6, 2023 | Jul 5, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jul 6, 2023 | Jul 6, 2023 |
| 8-K |
Current report
Shareholder vote results
|
May 30, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 4 | Insider transaction | May 3, 2023 | May 1, 2023 |
| 3 | Initial insider ownership | May 3, 2023 | May 1, 2023 |
| 8-K |
Current report
Listing notice
|
Apr 26, 2023 | Apr 20, 2023 |
| ARS | Annual report to shareholders | Apr 11, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 11, 2023 | — |
| DEF 14A | Proxy statement | Apr 11, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Mar 13, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change
|
Mar 13, 2023 | Mar 7, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 4 | Insider transaction | Jan 24, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 23, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 20, 2023 |
| 4 | Insider transaction | Jan 24, 2023 | Jan 20, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Jan 20, 2023 | — |
| 10-Q | Quarterly report | Nov 9, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2022 | Nov 9, 2022 |
| 8-K |
Current report
Listing notice
|
Oct 26, 2022 | Oct 21, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRIS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Lexington, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1108205
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.